Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) Financial Statements

Scinai Immunotherapeutics Ltd. American Depositary Shares

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG007TGL3Q9

XNAS · usd

1.70▲ 0.00 (0.00%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close1.70

Day's Range1.65 – 1.84

52-Week Range0.21 – 3.58

Volume96.5K

Avg Volume433.4K

Share Statistics

Shares Outstanding

Employees45

ExchangeXNAS

Listed2015-05-12

Share count as of August 20, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI)

What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Market Cap?: Scinai Immunotherapeutics Ltd. American Depositary Shares's Market Cap is $46.1B, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Price / Sales?: Scinai Immunotherapeutics Ltd. American Depositary Shares's Price / Sales is 35145.3×, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Revenue (TTM)?: Scinai Immunotherapeutics Ltd. American Depositary Shares's Revenue (TTM) is $1.3M, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Net Income (TTM)?: Scinai Immunotherapeutics Ltd. American Depositary Shares's Net Income (TTM) is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA?: Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA is -$6.1M, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's Diluted EPS (TTM)?: Scinai Immunotherapeutics Ltd. American Depositary Shares's Diluted EPS (TTM) is -0.00, based on as-reported figures from SEC (XBRL) filings.
What is Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA Margin?: Scinai Immunotherapeutics Ltd. American Depositary Shares's EBITDA Margin is -466.9%, based on as-reported figures from SEC (XBRL) filings.